Antibiotic treatment of ceftriaxone-susceptible Serratia marcescens bacteremia: A multicenter, retrospective cohort study.

MLA

Mughrabi, Abdallah, et al. “Antibiotic Treatment of Ceftriaxone-Susceptible Serratia Marcescens Bacteremia: A Multicenter, Retrospective Cohort Study.” International Journal of Clinical Pharmacology and Therapeutics, vol. 63, no. 2, Feb. 2025, pp. 54–62. EBSCOhost, https://doi.org/10.5414/CP204652.

APA

Mughrabi, A., Maamari, J., Phillips, T., Alabbasi, A., Brooks, A., Nuriev, R., Zenkin, L., Jaber, B. L., & Nader, C. (2025). Antibiotic treatment of ceftriaxone-susceptible Serratia marcescens bacteremia: A multicenter, retrospective cohort study. International Journal of Clinical Pharmacology and Therapeutics, 63(2), 54–62. https://doi.org/10.5414/CP204652

Chicago

Mughrabi, Abdallah, Julian Maamari, Timothy Phillips, Afaq Alabbasi, Aislinn Brooks, Rinat Nuriev, Lisa Zenkin, Bertrand L Jaber, and Claudia Nader. 2025. “Antibiotic Treatment of Ceftriaxone-Susceptible Serratia Marcescens Bacteremia: A Multicenter, Retrospective Cohort Study.” International Journal of Clinical Pharmacology and Therapeutics 63 (2): 54–62. doi:10.5414/CP204652.